MedTrace Logo

To Evaluate the Safety and Effectiveness of Flow Modulation Device for Intracranial Aneurysms

NCT06158750 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2024-06-27

No results posted yet for this study

Summary

The purpose of this study is to assess safety and effectiveness of the p64/p48 MW HPC Flow Modulation Device.

Conditions

  • Intracranial Aneurysm

Interventions

DEVICE

p64/p48 MW HPC Flow Modulation Device

Endovascular intervention with p64/p48 MW HPC Flow Modulation Device was performed in patients diagnosed with intracranial aneurysms

Sponsors & Collaborators

  • Phenox GmbH

    collaborator INDUSTRY

  • Beijing Wallaby Medical Technologies Co.,Inc.

    collaborator UNKNOWN

  • Shanghai Wallaby Medical Technologies Co.,Inc.

    lead INDUSTRY

Principal Investigators

  • Hongqi Zhang · Xuanwu Hospital, Beijing

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-17
Primary Completion
2026-02-28
Completion
2026-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06158750 on ClinicalTrials.gov